nicotinic agonists

Preferred Label : nicotinic agonists;

MeSH definition : Drugs that bind to and activate nicotinic cholinergic receptors (RECEPTORS, NICOTINIC). Nicotinic agonists act at postganglionic nicotinic receptors, at neuroeffector junctions in the peripheral nervous system, and at nicotinic receptors in the central nervous system. Agents that function as neuromuscular depolarizing blocking agents are included here because they activate nicotinic receptors, although they are used clinically to block nicotinic transmission.;

MeSH synonym : nicotinic cholinergic agonist; agonist, nicotinic; agonist, nicotinic cholinergic; cholinergic agonists, nicotinic; agonists, nicotinic; nicotinic agonist; cholinergic agonist, nicotinic; agonists, nicotinic cholinergic; nicotinic cholinergic agonists;

MeSH annotation : GEN or unspecified; prefer specifics; DF: NICOTINIC AGON or NICOTINIC AG;

Wikipedia link : https://en.wikipedia.org/wiki/Nicotinic agonist;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D018722;

UMLS CUI

C0242948;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Nicotinic receptor agonist (disposition) [SNOMED CT concept]
- Substance with nicotinic receptor agonist mechanism of action (substance) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Nicotinic Agonist [NCIt concept]
Indexing information
- 1-(5-chloropyridin-3-yl)-(1,4)diazepane [MeSH Supplementary Concept]
- 3-(3-(pyridine-3-yl)-1,2,4-oxadiazol-5-yl)benzonitrile [MeSH Supplementary Concept]
- 3-(3-bromothiophen-2-yl)-8-methyl-8-azabicyclo(3.2.1)oct-2-ene [MeSH Supplementary Concept]
- 3-N-benzyloxy-3-hydroxyimino-2-oxo-6,7,8,9-tetrahydro-1H-benzo(g)indole-5-sulfonamide [MeSH Supplementary Concept]
- 5-methyl-N-(2-(pyridin-3-ylmethyl)-1-azabicyclo(2.2.2)oct-3-yl)thiophene-2-carboxamide [MeSH Supplementary Concept]
- 7-chloro-N-quinuclidin-3-yl-benzo(b)thiophene-2-carboxamide [MeSH Supplementary Concept]
- N-(1-azabicyclo(2.2.2)oct-3-yl)(5-(2-pyridyl)thiopene-2-carboxamide) [MeSH Supplementary Concept]
- PNU-282987 [MeSH Supplementary Concept]
- laburnamine [MeSH Supplementary Concept]
MeSH Descriptor(s) used for indexing
- receptors, nicotinic [MeSH Descriptor]
Record concept(s)
- nicotinic agonists [MeSH concept]
See also
- ganglionic stimulants [MeSH Descriptor]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- (4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride [MeSH Descriptor]
- 3'-(5-chlorothiophen-2-yl)spiro-1-azabicyclo(2.2.2)octane-3,5'-(1',3')-oxazolidin-2'-one [MeSH Supplementary Concept]
- 3-(2,4-dimethoxybenzylidene)anabaseine [MeSH Supplementary Concept]
- N-(3-fluorobenzyl)-N-methylethanolamine [MeSH Supplementary Concept]
- Varenicline [MeSH Descriptor]
- dimethylphenylpiperazinium iodide [MeSH Descriptor]
- epibatidine [MeSH Supplementary Concept]
- lobeline [MeSH Descriptor]
- nicotine [MeSH Descriptor]
UMLS correspondences (same concept)
- Nicotinic Agonist [NCIt concept]
- Product containing nicotinic receptor agonist (product) [SNOMED CT concept]
- Substance with nicotinic receptor agonist mechanism of action (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients